JP2022535894A5 - - Google Patents

Info

Publication number
JP2022535894A5
JP2022535894A5 JP2021572445A JP2021572445A JP2022535894A5 JP 2022535894 A5 JP2022535894 A5 JP 2022535894A5 JP 2021572445 A JP2021572445 A JP 2021572445A JP 2021572445 A JP2021572445 A JP 2021572445A JP 2022535894 A5 JP2022535894 A5 JP 2022535894A5
Authority
JP
Japan
Prior art keywords
solid oral
approximately
oral preparation
total weight
amisulpride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021572445A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022535894A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/036084 external-priority patent/WO2020247603A1/en
Publication of JP2022535894A publication Critical patent/JP2022535894A/ja
Publication of JP2022535894A5 publication Critical patent/JP2022535894A5/ja
Pending legal-status Critical Current

Links

JP2021572445A 2019-06-04 2020-06-04 放出調節製剤およびその使用 Pending JP2022535894A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962856863P 2019-06-04 2019-06-04
US62/856,863 2019-06-04
US202063011584P 2020-04-17 2020-04-17
US63/011,584 2020-04-17
PCT/US2020/036084 WO2020247603A1 (en) 2019-06-04 2020-06-04 Modified release formulations and uses thereof

Publications (2)

Publication Number Publication Date
JP2022535894A JP2022535894A (ja) 2022-08-10
JP2022535894A5 true JP2022535894A5 (enExample) 2023-06-13

Family

ID=73652146

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021572445A Pending JP2022535894A (ja) 2019-06-04 2020-06-04 放出調節製剤およびその使用

Country Status (4)

Country Link
US (1) US20220323409A1 (enExample)
EP (1) EP3980008A4 (enExample)
JP (1) JP2022535894A (enExample)
WO (1) WO2020247603A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020011189A2 (pt) 2017-12-05 2020-11-17 Sunovion Pharmaceuticals Inc. misturas não racêmicas e usos das mesmas
KR20200110317A (ko) 2017-12-05 2020-09-23 선오비온 파마슈티컬스 인코포레이티드 결정형 및 이의 제조 방법
CA3142355A1 (en) 2019-06-04 2020-12-10 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof
CN115487161B (zh) * 2022-11-18 2023-03-03 山东则正医药技术有限公司 一种氨磺必利片的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique
WO2010023690A2 (en) * 2008-08-28 2010-03-04 Torrent Pharmaceuticals Ltd. Prolonged release formulation of amisulpride
GB201004020D0 (en) * 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
US10441544B2 (en) * 2017-10-10 2019-10-15 Douglas Pharmaceuticals, Ltd. Extended release pharmaceutical formulation
BR112020011189A2 (pt) * 2017-12-05 2020-11-17 Sunovion Pharmaceuticals Inc. misturas não racêmicas e usos das mesmas
CA3142355A1 (en) * 2019-06-04 2020-12-10 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof

Similar Documents

Publication Publication Date Title
TWI241911B (en) Sustained release ranolazine formulations
JP2022535894A5 (enExample)
EP2486918A2 (en) Pharmaceutical composition with both immediate and extended release characteristics
EP2623099A1 (en) Composition and method for treating neurological disease
JP2022535893A5 (enExample)
KR101156054B1 (ko) 안정한 에페리손 함유 서방성 의약조성물
CN105431144A (zh) 阿坎酸制剂、使用阿坎酸制剂的方法以及包含阿坎酸制剂的组合
AU2012349771A1 (en) Methods for treating cardiovascular disorder
EP3013327B1 (en) Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin
WO2021129735A1 (zh) 一种固体制剂及其制备方法和用途
JP6316422B2 (ja) フィンゴリモドの医薬組成物
JP2006528604A5 (enExample)
JP2009545546A (ja) リウマチ性疾患の遅延放出型グルココルチコイド治療
JP7558593B2 (ja) イブプロフェン制御放出錠及びその調製方法
CN115518066A (zh) 一种用于治疗抗凝血的药物组合物及应用
CN101342177B (zh) 氯诺昔康双层缓释片
KR101697773B1 (ko) 독소필린을 포함하는 변형 방출 조성물
CN120114401A (zh) 一种布立西坦缓释药物组合物、其制备方法及应用
WO2006088864A1 (en) Controlled release compositions comprising levetiracetam
CN110251473A (zh) 羟哌吡酮口服缓释制剂
CN101002755A (zh) 一种组合脉冲释放制剂及其制备方法
EP3727365A2 (en) Modified release formulations of flurbiprofen
KR20140118412A (ko) 활성 성분으로 에페리손을 함유하는 서방성 제제 조성물
TW202245772A (zh) 一種衣殼蛋白抑制劑的醫藥組成物及其製備方法
WO2021132302A1 (ja) 透析移行又は腎死の抑制のための薬剤